• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

氯氮平对慢性精神分裂症门诊患者吸烟的影响。

Effects of clozapine on smoking in chronic schizophrenic outpatients.

作者信息

George T P, Sernyak M J, Ziedonis D M, Woods S W

机构信息

Department of Psychiatry, Yale University School of Medicine, CT, USA.

出版信息

J Clin Psychiatry. 1995 Aug;56(8):344-6.

PMID:7635849
Abstract

BACKGROUND

The effects of clozapine administration on smoking were examined in chronic schizophrenic outpatients.

METHOD

Twenty-nine of 30 schizophrenic outpatients enrolled in a university-affiliated Community Mental Health Center clozapine clinic were retrospectively surveyed by semistructured questionnaire regarding smoking before and after clozapine administration.

RESULTS

Smokers comprised 62% (N = 18) of patients, and within this group, there was a significant decrease in reported daily cigarette use during clozapine treatment compared with level of use when patients had been treated with typical neuroleptics (1.67 +/- 1.13 vs. 1.26 +/- 0.72 packs/day, p = .025).

CONCLUSION

Clozapine may alter smoking behaviors in chronic schizophrenics.

摘要

背景

在慢性精神分裂症门诊患者中研究了氯氮平给药对吸烟的影响。

方法

通过半结构化问卷对一所大学附属社区心理健康中心氯氮平诊所登记的30例精神分裂症门诊患者中的29例进行回顾性调查,了解其在服用氯氮平前后的吸烟情况。

结果

吸烟者占患者的62%(N = 18),在该组中,与使用典型抗精神病药物治疗时相比,氯氮平治疗期间报告的每日吸烟量显著减少(1.67±1.13包/天对1.26±0.72包/天,p = 0.025)。

结论

氯氮平可能会改变慢性精神分裂症患者的吸烟行为。

相似文献

1
Effects of clozapine on smoking in chronic schizophrenic outpatients.氯氮平对慢性精神分裂症门诊患者吸烟的影响。
J Clin Psychiatry. 1995 Aug;56(8):344-6.
2
Acute risperidone treatment did not increase daily cigarette consumption or plasma levels of cotinine and caffeine: a pilot study.急性利培酮治疗未增加每日香烟消费量或可替宁及咖啡因的血浆水平:一项初步研究。
Hum Psychopharmacol. 2008 Jun;23(4):327-32. doi: 10.1002/hup.928.
3
Treatment pathway and patterns of clozapine prescribing for schizophrenia in New Zealand.新西兰精神分裂症患者氯氮平处方的治疗途径与模式
Ann Pharmacother. 2008 Jun;42(6):852-60. doi: 10.1345/aph.1K662. Epub 2008 May 13.
4
The effects of clozapine on aggression and substance abuse in schizophrenic patients.氯氮平对精神分裂症患者攻击行为和物质滥用的影响。
J Clin Psychiatry. 1999;60 Suppl 12:43-6.
5
Risperidone as an adjunct to clozapine therapy in chronic schizophrenics.利培酮作为氯氮平治疗慢性精神分裂症患者的辅助用药。
J Clin Psychiatry. 1996 Sep;57(9):395-7.
6
Gender differences in neuroleptic nonresponsive clozapine-treated schizophrenics.氯氮平治疗的精神分裂症患者中无反应性的性别差异。
Biol Psychiatry. 1996 Feb 15;39(4):249-54. doi: 10.1016/0006-3223(95)00138-7.
7
Clozapine maintenance therapy in schizophrenia.氯氮平在精神分裂症中的维持治疗
Prog Neuropsychopharmacol Biol Psychiatry. 2004 May;28(3):465-9. doi: 10.1016/j.pnpbp.2003.11.011.
8
Gating of auditory P50 in schizophrenics: unique effects of clozapine.精神分裂症患者听觉P50的门控:氯氮平的独特作用。
Biol Psychiatry. 1996 Aug 1;40(3):181-8. doi: 10.1016/0006-3223(95)00371-1.
9
Early developmental differences between DSM-III-R schizophrenics treated with clozapine and typical neuroleptics.接受氯氮平治疗的《精神疾病诊断与统计手册》第三版修订本(DSM-III-R)精神分裂症患者与接受传统抗精神病药物治疗的患者之间的早期发育差异。
J Psychiatr Res. 1998 Mar-Apr;32(2):105-10. doi: 10.1016/S0022-3956(98)00056-9.
10
Clinical effects of a randomized switch of patients from clozaril to generic clozapine.患者从氯氮平随机转换为氯氮平仿制药的临床效果。
J Clin Psychiatry. 2001;62 Suppl 5:14-7; discussion 23-4.

引用本文的文献

1
Canonical and Non-Canonical Antipsychotics' Dopamine-Related Mechanisms of Present and Next Generation Molecules: A Systematic Review on Translational Highlights for Treatment Response and Treatment-Resistant Schizophrenia.经典和非经典抗精神病药物与现有和下一代分子的多巴胺相关机制:针对治疗反应和治疗抵抗性精神分裂症的转化研究亮点的系统综述。
Int J Mol Sci. 2023 Mar 21;24(6):5945. doi: 10.3390/ijms24065945.
2
Differences in olfactory dysfunction and its relationship with cognitive function in schizophrenia patients with and without auditory verbal hallucinations.有和没有幻听的精神分裂症患者嗅觉功能障碍的差异及其与认知功能的关系。
Eur Arch Psychiatry Clin Neurosci. 2023 Dec;273(8):1813-1824. doi: 10.1007/s00406-023-01589-8. Epub 2023 Mar 22.
3
Binding of clozapine to the GABA receptor: clinical and structural insights.氯氮平与GABA受体的结合:临床与结构见解
Mol Psychiatry. 2020 Sep;25(9):1910-1919. doi: 10.1038/s41380-020-0709-5. Epub 2020 Mar 13.
4
A retrospective cohort study of the prevalence of anxiety and agitation in schizophrenic smokers and the unmet needs of smoking cessation programs.一项关于精神分裂症吸烟者焦虑和激越患病率及戒烟项目未满足需求的回顾性队列研究。
Medicine (Baltimore). 2019 Oct;98(40):e17375. doi: 10.1097/MD.0000000000017375.
5
The relationship between nicotine and psychosis.尼古丁与精神病之间的关系。
Ther Adv Psychopharmacol. 2019 Jul 1;9:2045125319859969. doi: 10.1177/2045125319859969. eCollection 2019.
6
Potent Dopamine D2 Antagonists Block the Reward-Enhancing Effects of Nicotine in Smokers With Schizophrenia.强效多巴胺 D2 拮抗剂阻断精神分裂症吸烟者的尼古丁奖赏增强效应。
Schizophr Bull. 2019 Oct 24;45(6):1300-1308. doi: 10.1093/schbul/sby185.
7
Clozapine, Diabetes Mellitus, Cardiovascular Risk and Mortality: Results of a 21-Year Naturalistic Study in Patients with Schizophrenia and Schizoaffective Disorder.氯氮平、糖尿病、心血管风险与死亡率:一项针对精神分裂症和分裂情感性障碍患者的21年自然主义研究结果
Clin Schizophr Relat Psychoses. 2019 Winter;12(4):168-176. doi: 10.3371/CSRP.KNMG.111717. Epub 2017 Nov 22.
8
The link between schizophrenia and substance use disorder: A unifying hypothesis.精神分裂症与物质使用障碍之间的关联:一个统一的假说。
Schizophr Res. 2018 Apr;194:78-85. doi: 10.1016/j.schres.2017.04.016. Epub 2017 Apr 14.
9
An analysis of the rewarding and aversive associative properties of nicotine in the neonatal quinpirole model: Effects on glial cell line-derived neurotrophic factor (GDNF).分析新生期喹吡罗模型中尼古丁的奖赏和厌恶关联特性:对胶质细胞源性神经营养因子(GDNF)的影响。
Schizophr Res. 2018 Apr;194:107-114. doi: 10.1016/j.schres.2017.03.024. Epub 2017 Mar 14.
10
Predictors of tobacco abstinence in outpatient smokers with schizophrenia or bipolar disorder treated with varenicline and cognitive behavioral smoking cessation therapy.使用伐尼克兰和认知行为戒烟疗法治疗的精神分裂症或双相情感障碍门诊吸烟者戒烟的预测因素。
Addict Behav. 2017 Aug;71:89-95. doi: 10.1016/j.addbeh.2017.02.028. Epub 2017 Feb 24.